Riik: Malaisia
keel: inglise
Allikas: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
Bromhexine HCl
DUOPHARMA MANUFACTURING (BANGI) SDN BHD
Bromhexine HCl
30Tablet Tablets; 12x30`s Tablets
DUOPHARMA MANUFACTURING (BANGI) SDN BHD
_CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP) _ 1 BEACOLYTIC ELIXIR/TABLET Bromhexine hydrochloride (4mg/5ml , 8mg) WHAT IS IN THE LEAFLET 1. What Beacolytic is used for 2. How Beacolytic works 3. Before you use Beacolytic 4. How to use Beacolytic 5. While you are using it 6. Side effects 7. Storage and Disposal of Beacolytic 8. Product Description 9. Manufacturer and Product Registration Holder 10. Date of Revision WHAT BEACOLYTIC IS USED FOR Beacolytic is used to reduce phlegm thickness, thus facilitate its removal by coughing. HOW BEACOLYTIC WORKS Beacolytic contains bromhexine hydrochloride as an active ingredient. Bromhexine hydrochloride helps to clear the chest by thinning the phlegm in your air passages. BEFORE YOU USE BEACOLYTIC - _When you must not take it _ Do not take this medicine if you have an allergy to: Bromhexine hydrochloride any of the other ingredients listed at the end of this leaflet Do not take this medicine after the expiry date printed on the pack or if the packaging is torn or shows signs of tampering. If it has expired or is damaged, return it to your pharmacist for disposal. If you are not sure whether you should start taking this medicine, talk to your doctor. - _Before you start to use it _ Tell your doctor if you have - allergies to any other medicines, foods, preservatives or dyes - gastric ulcer. Ask your doctor or pharmacist for advice before taking this medicine if you are pregnant or breastfeeding. - _Taking other medicines _ Tell your doctor or pharmacist if you are taking any other medicines, including any that you get without a prescription from your pharmacy, supermarket or health food shop. Some medicines and Beacolytic may interfere with each other. You may need different amounts of your medicines, or you may need to take different medicines. Your doctor and pharmacist have more information on medicines to be careful with or avoid while taking this medicine. HOW TO USE BEACOLYTIC Follow all directions given to you by your doctor and pharmacist carefully. These Lugege kogu dokumenti
PRODUCT INFORMATION BEACOLYTIC TABLET/ELIXIR BEACOLYTIC contains Bromhexine HCI. It is a mucolytic agent facilitating expectoration by reducing sputum viscosity and relieving wet cough. PRODUCT DESCRIPTION TABLET: A 7 mm in diameter, round, flat, plain yellow tablet. ELIXIR: A plain, strawberry flavoured syrup. PHARMACODYNAMICS Bromhexine HCl can facilitate expectoration by reducing sputum viscosity in chronic asthma and bronchitis. PHARMACOKINETICS Bromhexine HCl is absorbed from the G.I.T and peak plasma concentrations occurs after 1 hour. Most of the dose is excreted in the urine mainly as metabolites. INDICATION Reduction in sputum viscosity, thus facilitate its removal by coughing. DOSAGE Adults and children above 12 years: 1 to 2 tablets three times daily or 10ml three times daily OR as directed by physician. Children under 6 years: 5 ml twice d a i l y . Children 6 to 12 years: 5ml three t i m e s daily OR as directed by physician. It‘s advisable to drink more warm water. ADVERSE EFFECTS/UNDESIRABLE EFFECTS: Gastrointestinal irritation, transient increased serum transaminase. Immune System Disorders Frequency not known: Anaphylactic reactions including anaphylactic shock. Skin and Subcutaneous Skin Disorders Frequency not known: Severe skin reactions (including Stevens Johnson syndrome, Toxic epidermal necrolysis (TEN), Erythema Multiforme (EM) and Acute Generalized Exanthematous Pustulosis (AGEP). WARNINGS AND PRECAUTIONS: Gastric Ulceration. Very rare cases of chronically associated severe skin impairments such as Stevens Johnson Syndrome, Toxic Epidermal Necrolysis (TEN), Erytheme Multiforme (EM) and Acute Generalized Exanthematous Pustulosis (AGEP) have been reported. In most cases, these could be explained by the severity of the underlying disease or concomitant administra- tion of another drug. In the early stages of such severe skin reactions, initially only nonspecific flu-like symptoms appear, e.g. fever, arthralgia, runny nose, cough, and sore throat. If skin or mucous membrane damage occurs, s Lugege kogu dokumenti